SFP
Sterling Financial Planning Portfolio holdings
AUM
$299M
1-Year Return
13.08%
This Quarter Return
-1.48%
1 Year Return
+13.08%
3 Year Return
+40.95%
5 Year Return
–
10 Year Return
–
AUM
$157M
AUM Growth
+$3.12M
(+2%)
Cap. Flow
+$5.58M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
47.46%
Holding
435
New
33
Increased
110
Reduced
60
Closed
7
Top Buys
Top Sells
| 1 |
Pfizer
PFE
|
$296K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$169K |
| 3 |
Meta Platforms (Facebook)
META
|
$162K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$130K |
| 5 |
LBAI
Lakeland Bancorp Inc
LBAI
|
$105K |
Sector Composition
| 1 | Technology | 3.08% |
| 2 | Financials | 2.79% |
| 3 | Healthcare | 2.73% |
| 4 | Industrials | 1.93% |
| 5 | Consumer Discretionary | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Delta Air Lines
DAL
$40.5B
| – | – |
-795
| Closed | -$34K |
|
427
NVIDIA
NVDA
$4.16T
| – | – |
-1,320
| Closed | -$26K |
|
428
Rackspace Technology
RXT
$309M
| – | – |
-700
| Closed | -$14K |
|
|
CDMO
429
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $0 | ﹤0.01% |
9
| – | – |
|
|
DRNA
430
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-100
| Closed | -$4K |
|
|
KCAC
431
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| – | – |
-346
| Closed | -$10K |
|
|
ALXN
432
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-18
| Closed | -$3K |
|
433
Atlanta Braves Holdings Series A
BATRA
$2.88B
| $0 | ﹤0.01% |
9
| – | – |
|
|
CELG.RT
434
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
$73.3M
| $0 | ﹤0.01% |
375
| – | – |
|
|
CGC
435
Canopy Growth
CGC
$424M
| – | – |
-18
| Closed | -$4K |
|